Ain Holdings refinances funds for pharmacy acquisitions

Ain Holdings announced on December 25, 2025, that its board of directors resolved to refinance previously acquired funds. This refinancing follows the acquisition of all shares of NSSK-WW Co., Ltd. (now AIN-AG1 Co., Ltd.) and NSSK-W Co., Ltd. (now AIN-AG2 Co., Ltd.), which own shares of Sakura Pharmacy Co., Ltd. and other companies. These acquisitions were initially announced on May 29, 2025.

The company had previously borrowed funds from Sumitomo Mitsui Banking Corporation, as disclosed on July 30, 2025, to finance these acquisitions. The current refinancing aims to convert these funds into a mix of variable-rate and fixed-rate loans. The total amount of borrowings is 125,000 million yen, with a borrowing date of January 30, 2026, and a 10-year borrowing period. The eight financial institutions involved include Sumitomo Mitsui Banking Corporation, MUFG Bank, Ltd., Mizuho Bank, Ltd., and others. Ain Holdings expects the impact of this refinancing on its business performance to be immaterial.